|
OMIM |
Link |
Information gain |
01 |
|
hypokalemia, familial
|
[NCBI]
|
0.0063823
|
|
|
adrenal unresponsiveness to acth
|
[NCBI]
|
0.0040403
|
|
|
GRA
|
[NCBI]
|
0.00321773
|
|
|
NPPA
|
[NCBI]
|
0.00280777
|
|
|
AVP
|
[NCBI]
|
0.00258238
|
|
|
hyperreninemic hypoaldosteronism, familial, 2
|
[NCBI]
|
0.00235325
|
|
|
diarrhea 3, secretory sodium, congenital
|
[NCBI]
|
0.00183065
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.00183065
|
|
|
PHA1
|
[NCBI]
|
0.00157638
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
0.00146856
|
|
|
PHA2
|
[NCBI]
|
0.00111823
|
|
|
GCCD1
|
[NCBI]
|
0.000740769
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
0.000644859
|
|
|
AME2
|
[NCBI]
|
0.00056478
|
|
|
liddle syndrome
|
[NCBI]
|
0.000521006
|
|
|
CYP11B2
|
[NCBI]
|
0.000446558
|
|
|
RA
|
[NCBI]
|
0.000418039
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
0.000338358
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
0.000300795
|
|
|
ADM
|
[NCBI]
|
0.000224441
|
|
|
pseudohypoaldosteronism, type i, autosomal dominant
|
[NCBI]
|
0.000205493
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
0.000195193
|
|
|
polycystic kidneys
|
[NCBI]
|
0.000156576
|
|
|
SLE
|
[NCBI]
|
0.000155927
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
0.000145314
|
|
|
hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy
|
[NCBI]
|
0.000140931
|
|
|
ataxia-deafness-retardation syndrome
|
[NCBI]
|
0.000140931
|
|
|
proopiomelanocortin deficiency
|
[NCBI]
|
9.75099e-05
|
|
|
NR3C2
|
[NCBI]
|
9.55515e-05
|
|
|
TNF
|
[NCBI]
|
9.19173e-05
|
|
|
hypertension, essential
|
[NCBI]
|
8.95216e-05
|
|
|
REN
|
[NCBI]
|
8.86188e-05
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
7.95606e-05
|
|
|
SERPINA6
|
[NCBI]
|
7.52627e-05
|
|
|
APS1
|
[NCBI]
|
7.04727e-05
|
|
|
por deficiency
|
[NCBI]
|
6.72723e-05
|
|
|
HOMG3
|
[NCBI]
|
6.30089e-05
|
|
|
thyrotropin deficiency, isolated
|
[NCBI]
|
6.11545e-05
|
|
|
VEGF
|
[NCBI]
|
5.74789e-05
|
|
|
WNK4
|
[NCBI]
|
5.70504e-05
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
5.6391e-05
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
5.13454e-05
|
|
|
AAA
|
[NCBI]
|
5.02523e-05
|
|
|
HOKPP
|
[NCBI]
|
4.92136e-05
|
|
|
AHC
|
[NCBI]
|
4.55122e-05
|
|
|
NGFB
|
[NCBI]
|
4.46187e-05
|
|
|
VIP
|
[NCBI]
|
4.25509e-05
|
|
|
CF
|
[NCBI]
|
3.82026e-05
|
|
|
PCNA
|
[NCBI]
|
3.45148e-05
|
|
|
PRL
|
[NCBI]
|
3.43137e-05
|
|
|
CYP11A1
|
[NCBI]
|
3.04898e-05
|
|
|
GCCR
|
[NCBI]
|
3.02339e-05
|
|
|
SCNN1B
|
[NCBI]
|
2.93248e-05
|
|
|
AQP2
|
[NCBI]
|
2.89858e-05
|
|
|
CMH
|
[NCBI]
|
2.65012e-05
|
|
|
CYP11B1
|
[NCBI]
|
2.56688e-05
|
|
|
STAR
|
[NCBI]
|
2.38014e-05
|
|
|
APC
|
[NCBI]
|
2.3748e-05
|
|
|
EGF
|
[NCBI]
|
2.24249e-05
|
|
|
GFAP
|
[NCBI]
|
2.19976e-05
|
|
|
CAMK1
|
[NCBI]
|
2.1745e-05
|
|
|
CALCRL
|
[NCBI]
|
2.13935e-05
|
|
|
CTGF
|
[NCBI]
|
2.11221e-05
|
|
|
GPR103
|
[NCBI]
|
1.99391e-05
|
|
|
QRFP
|
[NCBI]
|
1.99391e-05
|
|
|
TH
|
[NCBI]
|
1.97668e-05
|
|
|
EGFR
|
[NCBI]
|
1.87596e-05
|
|
|
CLDN8
|
[NCBI]
|
1.85998e-05
|
|
|
LPL
|
[NCBI]
|
1.72488e-05
|
|
|
CCK
|
[NCBI]
|
1.70749e-05
|
|
|
ACE
|
[NCBI]
|
1.6544e-05
|
|
|
APLP1
|
[NCBI]
|
1.58986e-05
|
|
|
MLPH
|
[NCBI]
|
1.52412e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.51432e-05
|
|
|
POR
|
[NCBI]
|
1.41361e-05
|
|
|
SCNN1G
|
[NCBI]
|
1.36624e-05
|
|
|
KLK1
|
[NCBI]
|
1.32294e-05
|
|
|
SLC26A3
|
[NCBI]
|
1.21182e-05
|
|
|
NPY
|
[NCBI]
|
1.18099e-05
|
|
|
KCNE1
|
[NCBI]
|
1.12117e-05
|
|
|
PRKCM
|
[NCBI]
|
1.08189e-05
|
|
|
FMF
|
[NCBI]
|
1.07246e-05
|
|
|
TSC22D3
|
[NCBI]
|
1.06894e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
1.04481e-05
|
|
|
MC2R
|
[NCBI]
|
1.02183e-05
|
|
|
EPO
|
[NCBI]
|
9.84975e-06
|
|
|
SLC12A3
|
[NCBI]
|
9.78976e-06
|
|
|
SLOS
|
[NCBI]
|
8.75812e-06
|
|
|
AR
|
[NCBI]
|
8.05164e-06
|
|
|
FABP3
|
[NCBI]
|
7.81991e-06
|
|
|
NR0B1
|
[NCBI]
|
7.56174e-06
|
|
|
VDR
|
[NCBI]
|
7.44872e-06
|
|
|
EDN1
|
[NCBI]
|
7.31803e-06
|
|
|
POMC
|
[NCBI]
|
6.74007e-06
|
|
|
CYP17A1
|
[NCBI]
|
6.46274e-06
|
|
|
AGT
|
[NCBI]
|
6.1826e-06
|
|
|
CRH
|
[NCBI]
|
5.37577e-06
|
|
|
ENPEP
|
[NCBI]
|
4.95389e-06
|
|
|
PENK
|
[NCBI]
|
4.46415e-06
|
|
|
FSHR
|
[NCBI]
|
4.46415e-06
|
|
|
MEN1
|
[NCBI]
|
3.70008e-06
|
|
|
PPARA
|
[NCBI]
|
3.62845e-06
|
|
|
NMB
|
[NCBI]
|
3.35653e-06
|
|
|
ALD
|
[NCBI]
|
2.77312e-06
|
|
|
CFTR
|
[NCBI]
|
2.76376e-06
|
|
|
GAPDH
|
[NCBI]
|
2.5878e-06
|
|
|
INS
|
[NCBI]
|
2.2701e-06
|
|
|
CNTF
|
[NCBI]
|
2.02392e-06
|
|
|
G6PD
|
[NCBI]
|
1.85008e-06
|
|
|
ADCYAP1
|
[NCBI]
|
1.38333e-06
|
|
|
CASR
|
[NCBI]
|
1.32305e-06
|
|
|
GAL
|
[NCBI]
|
1.05342e-06
|
|
|
ALB
|
[NCBI]
|
8.22235e-07
|
|
|
KCNH2
|
[NCBI]
|
6.78821e-07
|
|
|
PTH
|
[NCBI]
|
6.0421e-07
|
|
|
GIP
|
[NCBI]
|
3.45325e-07
|
|
|
TLR2
|
[NCBI]
|
3.32284e-07
|
|
|
GHR
|
[NCBI]
|
2.3135e-07
|
|
|
SPP1
|
[NCBI]
|
1.62791e-07
|
|
|
SDC2
|
[NCBI]
|
1.5963e-07
|
|
|
PYY
|
[NCBI]
|
1.06948e-07
|
|
|
ABCC1
|
[NCBI]
|
9.23262e-08
|
|